ST
HZNP

Smithfield Trust’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Smithfield Trust’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20
Closed -$2K – 1065
2023
Q3 		$2K Hold
20
– – ﹤0.01% 986
2023
Q2 		$2K Hold
20
– – ﹤0.01% 1005
2023
Q1 		$2K Sell
20
-370
-95% -$40.9K ﹤0.01% 972
2022
Q4 		$44K Hold
390
– – ﹤0.01% 531
2022
Q3 		$25K Sell
390
-1,902
-83% -$133K ﹤0.01% 614
2022
Q2 		$183K Sell
2,292
-20
-0.9% -$1.89K 0.01% 301
2022
Q1 		$243K Hold
2,312
– – 0.02% 276
2021
Q4 		$249K Sell
2,312
-14
-0.6% -$1.53K 0.02% 289
2021
Q3 		$253K Hold
2,326
– – 0.02% 273
2021
Q2 		$218K Sell
2,326
-20
-0.9% -$1.84K 0.01% 300
2021
Q1 		$215K Buy
2,346
+1,742
+288% +$147K 0.01% 297
2020
Q4 		$44K Hold
604
– – ﹤0.01% 550
2020
Q3 		$47K Buy
+604
New +$41.6K ﹤0.01% 515

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Smithfield Trust's HZNP Position: Q4 2023 in Review

Smithfield Trust sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 20 shares — an estimated $2K sold.

Smithfield Trust first reported a position in HZNP in Q3 2020 and held it in 13 quarters. The position peaked at $253K in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Smithfield Trust reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Smithfield Trust sold 20 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2K.
  • Smithfield Trust first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 13 quarters.
  • Smithfield Trust's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $253K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Smithfield Trust's 13F filing for Q4 2023, filed 7 Feb 2024.